抄録
One hundred and eleven cases of rhabdomyosarcoma were analysed on prognosis in this report. In the latter five years, the two-year tumor-free survival rate was significantly better. That was 45.7% (21/46) versus 25.5% (12/47). On operation, total resection, sub-total resection and other operative methods were compared in relation to age and site of tumor occurence. Between 1 and 3 years of age, total resection was better than other operative methods. In the totally resected group, the age between 1 and 3 was better than other age groups. On radiotherapy, the tumor-free two-year survival rates were compared among without radiation, under 3,500rad and over 3,500rad, in relation to stages. Only in the group over 3,500rad, Stage I was better than other stages significantly. On chemotherapy, VAC therapy was used only in 21.1% in the former 5 years, while it was used in 57.5% in the latter 5 years with or without use of Adriamycin. VAC therapy used over 6 months gave significantly better prognosis. VAC therapy did not give better results in any stages, when studied statistically. The problem was shortage of case number in this study. The analysed results were stored for future comparison in the same basis.
